Zepbound · Starting out
Your first week on Zepbound
Published by MALAI · Last updated
Week one is 2.5 mg of tirzepatide — the same molecule, same starting dose and same six-step ladder as Mounjaro. The difference is the licence: Zepbound is approved for weight management, which is why you are more likely to have been prescribed it deliberately for that purpose rather than off-label.
What happens, day by day
Day 1
Inject. Appetite suppression often begins within 24–48 hours, faster than the semaglutide drugs. Injection site reactions are reported in 6–8% of Zepbound patients against 2% on placebo — higher than on semaglutide, and usually mild redness rather than anything systemic.
Days 1–3
If nausea appears, here. The label reports 25% on 5 mg and 29% on 10 mg versus 8% on placebo; the 2.5 mg starting dose sits below that range. Expect to feel flat as well: fatigue, grouped on the label with asthenia, lethargy and malaise, ran at 5 to 7% against 3% on placebo (section 6.1, table 1).
Days 4–7
Fullness arrives several bites earlier than it used to. Because Zepbound is prescribed specifically for weight loss, most people are also in a deliberate deficit — which makes week one the point where protein has to become intentional.
End of week 1
Two to five pounds is common and largely water. Meaningful fat loss starts after the first month.
Where 2.5 mg sits in the ladder
2.5 mg → 5 → 7.5 → 10 → 12.5 → 15 mg over sixteen weeks, identical to Mounjaro. By week 4 you are still at 2.5 mg or stepping to 5 mg. Zepbound produces the largest average weight losses of any GLP-1 currently approved, which is also why lean-mass protection matters more here than anywhere else on this site.
What to eat in week one
Your peak lands a median of 24 hours after the injection, anywhere from 8 to 72 (prescribing information, section 12.3) — so if one day is going to be rough, it is usually the day after rather than the day of. Put the plain meals there. But the bigger week-one problem on Zepbound is not nausea. It is that your appetite can fall further and faster than you are ready for, and take your protein down with it without you noticing. Zepbound produces the largest average weight losses of any GLP-1 approved so far, and the quicker weight comes off, the more of it can come from lean tissue rather than fat. Treat 1.4 to 1.6 g of protein per kg a day as the floor rather than the goal. If you change one thing this week, make it a protein-first breakfast — it is the meal you will still manage on the days you do not want the other two.
What Zepbound is licensed for — and why that matters now
Zepbound was approved for chronic weight management in 2023 — the licence Mounjaro does not have for that use. In practice that is what makes coverage arguable: an insurer can be asked to cover Zepbound for weight on-label, whereas tirzepatide prescribed as Mounjaro for the same purpose is off-label and routinely declined. Coverage is still far from guaranteed and prior authorisation is common, but the route exists.
First week on Mounjaro — the same tirzepatide, licensed differently →
What is normal, and what is worth a call
Expected: early fullness, some nausea, mild injection-site redness. Call your prescriber for vomiting you cannot keep fluids down through, severe abdominal pain, or an injection-site reaction that spreads or blisters rather than fading.
First week on the other GLP-1s:
Frequently asked questions
- What is actually different about Zepbound versus Mounjaro in week one?
- Clinically, nothing. Both are tirzepatide starting at 2.5 mg on an identical six-step ladder to 15 mg over sixteen weeks. The difference is regulatory: Zepbound holds FDA approval for chronic weight management from 2023, Mounjaro holds approval for type 2 diabetes. That determines which one an insurer can be asked to cover for weight, not how week one feels.
- Why does Zepbound cause injection site reactions more than Ozempic?
- The label reports them in 6–8% of Zepbound patients against 2% on placebo, which is higher than the semaglutide drugs report. They are usually mild — redness or itching at the site, fading over a day or two. Rotating injection sites and letting the pen reach room temperature before injecting both help. A reaction that spreads or blisters is worth a call.
- Why am I so tired for two days after my Zepbound shot?
- Partly the drug, partly something you can act on. Zepbound's label lists fatigue, grouped with asthenia, lethargy and malaise, in 5 to 7% of patients against 3% on placebo (prescribing information, section 6.1, table 1). That looks small beside how loudly people describe it, and there is a reason: the trials recorded whether fatigue happened, not when, so the day-after pattern is invisible in an incidence number. The part you can change is that barely eating for a day produces this tiredness by itself.
- I am still hungry in week one on Zepbound — has it not worked?
- Wait until week four before judging it. You are on 2.5 mg, a lead-in dose, and tirzepatide does not reach steady state until roughly four weeks of weekly dosing (prescribing information, section 12.3), so week one is the least drug you will ever have on board. Some people feel appetite drop within a day, others notice nothing until 5 mg, and neither predicts the outcome. Watch fullness rather than hunger: whether you are still finishing meals you would have finished a fortnight ago.
- Does injection site reactions start in the first week on Zepbound?
- Common on Zepbound overall. Reported by 6-8% against 2% on placebo in the prescribing information — notably higher than on the semaglutide drugs. Usually mild redness or itching at the site rather than a systemic reaction. In week one you are on 2.5 mg, below the doses those figures come from, so if it turns up at all it is usually milder than the label rate suggests.